STUDY QUESTION: Are hypoxia-inducible factors (HIF) responsible for the potentiation of inhibin alpha subunit (INHA) gene expression in primary cultures of human term cytotrophoblasts under low-oxygen tension?
Introduction
During pregnancy, the placenta plays the role of the interface between the mother and the fetus. It is an organ that fulfills several important functions. It protects the fetus from infections, allow gas exchange, nutrient transport and waste elimination. Another essential function is the production and secretion of hormones, cytokines and angiogenic growth factors to maintain the pregnancy and sustain fetal growth. Hormones produced by the placenta include progesterone, estrogens, corticotropin-releasing hormone, hCG, human placental lactogen, activin A and inhibin A.
Activins and inhibins are glycoproteins that belong to the transforming growth factor-beta superfamily (Ying, 1988) . They are formed of two subunits linked by a single disulfide bond. Activins consist of two beta subunits A or B (activin A, activin B or activin AB), and inhibins consist of one alpha subunit and one beta subunit A or B (inhibin A, inhibin B). Each subunit is encoded by a separate gene. Activins and inhibins are produced by the ovary, the testes, the pituitary, and during pregnancy, by the placenta and the fetal membranes. Activins stimulate production and secretion of FSHs while inhibins inhibit pituitary FSH production in a negative feedback loop. During pregnancy, the placenta is the main source of inhibin A. Maternal serum inhibin A increases during pregnancy from 177.5 pg/ml at 10 weeks gestation to reach 953 pg/ml at 37-42 weeks gestation (Kuijper et al., 2013) .
The exact role of inhibin A during pregnancy is not well established. Inhibin A secretion is elevated in pre-eclampsia (Bersinger et al., 2003) , preterm labor (Plevyak et al., 2003) , and in pregnancies associated with Down syndrome (Aitken et al., 1996) while low levels are associated with subsequent miscarriages (Muttukrishna et al., 2002) . It is currently a diagnostic marker measured in maternal serum in the quad screen test in combination with alpha-fetoprotein, hCG and estriol to identify pregnancies at risk for Down syndrome performed between 16th and 18th weeks of gestation (Dugoff et al., 2005) .
The human inhibin alpha (INHA) gene is located on 2q33-q36 and has two exons separated by a 1.7-kb intron (Stewart et al., 1986) . Two transcripts are produced but only one is translated into a 366 amino-acid precursor of 53 kDa that is further processed by proteolytic cleavage to give rise to the 18 kDa mature form (Makanji et al., 2014) . Understanding the transcriptional regulation of the INHA gene promoter is key to finding the regulatory mechanisms of inhibin A production and secretion. Different transcription factors, such as members of the GATA family (Anttonen et al., 2006) , steroidogenic factor-1 (Feng et al., 1998; Ito et al., 2000; Gummow et al., 2003) , NUR77 (He et al., 2013) , Wilms' tumor gene 1 (Ji et al., 2013) , inducible 3′,5′-cyclic adenosine monophosphate early repressor (Burkart et al., 2006) , CCAAT/enhancer-binding protein-beta (Burkart et al., 2005) , members of the NR5A family (Robert et al., 2006; Matulis and Mayo, 2012) , and transcription factor activating-enhancer binding protein-2 (TFAP2) (Debieve et al., 2011) with or without synergistic action of the cAMP-response element binding protein (CREB) (Depoix et al., 2014) have been identified in rodent ovaries and testes, and also in human placenta. Most of these transcription factors bind to response elements located within 600 bp upstream of the ATG translation initiation site of the INHA promoter.
Formation of the placenta during the first trimester probably occurs in a relatively hypoxic environment. Oxygen measurements in the placental cavity during the first trimester indicate that oxygen partial pressure is <20 mm Hg (Jauniaux et al., 2000) . This low-oxygen tension is explained by the formation of plugs by extra villous cytotrophoblasts at the tip of maternal spiral arteries, blocking maternal blood flow into the intervillous space (Hustin and Schaaps, 1987) . This first-trimester hypoxia is necessary to protect embryonic development from oxidative stress (Dennery, 2007) . It is also necessary for placenta formation by allowing proper regulation of gene expression involved in placental angiogenesis (Torry et al., 2007) . Between the 10th and the 12th week of gestation, the plugs disappear allowing maternal blood circulation into the placental cavity. This is followed by a rise in oxygen tension with a partial pressure of between 40 and 80 mm Hg (Jauniaux et al., 2001) . In some pregnancy-related diseases, such as early-onset preeclampsia and intrauterine growth restriction (IUGR), placenta formation is abnormal leading to smaller placentas (Fisher, 2015) . Invasion of the uterine tissue by extra-villous cytotrophoblasts and spiral artery physiological conversion (Kadyrov et al., 2006) are insufficient, leading to chronic hypoxia after the first trimester.
The hormone-secreting cells in the placenta are the syncytiotrophoblasts, cells that are multinucleated with undefined cellular limits. They form a layer of cells covering the surface of the placental villi and cavity called syncytium. This layer is constantly renewed by fusion with the underlying mononuclear cytotrophoblasts. Syncytialization is the differentiation of cytotrophoblasts into syncytiotrophoblasts and can be studied with in vitro cultures of primary cytotrophoblasts isolated and purified from term placentas. During in vitro syncytialization, typical genes of placenta formation like genes coding for hCG subunits, INHA, vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) among others are overexpressed. When syncytialization happens in a low-oxygen environment, gene expression is changed. Placental angiogenesis is affected by oxygen, and genes coding for proand anti-angiogenic factors are particularly studied. The PlGF gene is downregulated by hypoxia (Gobble et al., 2009; Debieve et al., 2013) , while genes coding for VEGF, the soluble form of its membrane receptor sVEGFR1, and also soluble endoglin are upregulated by hypoxia (Li et al., 2005) . It is well established that the heterodimer hypoxiainducible factor-1 (HIF-1) is responsible for gene upregulation, such as VEGF , under hypoxia (Wang et al., 1995) . This heterodimer is made of one alpha (HIF1A) and one beta (HIF1B) subunit. While HIF1B is constitutively present in the cell nucleus, HIF1A is destabilized by posttranslational modifications when the cells are cultured under normal oxygen tension, e.g. 21% O 2 of the air (Lee et al., 2004) . It is hydroxylated on prolines by prolyl-4-hydroxylases (PHD) (Bruick and McKnight, 2001 ) and acetylated on lysine residue by ARD1 acetyltransferase (Jeong et al., 2002) . Proline hydroxylation and lysine acetylation lead to interactions with von Hippel-Lindau tumor suppressor protein (Hon et al., 2002) and degradation through the ubiquitinproteasome pathway. PHD is a dioxygenase requiring oxygen and 2-oxoglutarate. When oxygen tension is low, PHD cannot hydroxylate HIF1A, which is therefore not degraded. It accumulates in the cytoplasm, and migrates to the nucleus to form a dimer with HIF1B that binds to hypoxia-responsive elements (HRE) in the promoter of target genes to regulate their expression.
Production and secretion of inhibin A are limited by the synthesis level of the inhibin alpha chain (Debieve et al., 2000) , and it is important to understand how its expression is regulated in syncytiotrophoblasts. We have already shown that INHA mRNA and protein expression is increased when cells cultured under regular cell culture conditions (e.g. 21% O 2 ) are undergoing syncytialization. It is even further increased when cells are cultured under low-oxygen tension, e.g. 2.5% O 2 (Debieve et al., 2013) . The purpose of the present study was to determine if the transcription factors HIF1 were responsible for increased INHA expression in differentiated cytotrophoblasts cultured under low-oxygen tension.
Material and Methods

Drugs
Dimethyloxalylglycine (DMOG), Deferoxamine mesylate salt (DFX) and KC7F2 were obtained from SIGMA-ALDRICH (St. Louis, MO, USA). TC-S7009 was obtained from Tocris Biosciences (Bristol, UK). DMOG and DFX were dissolved in water. KC7F2 and TC-S7009 were dissolved in 100% DMSO.
Reporter genes and expression vectors
A 3945 base pair fragment corresponding to nucleotides −3910 to +34 of the INHA promoter was amplified from human cytotrophoblast genomic DNA and cloned into pJET1.2 using CloneJET PCR Cloning Kit (Thermo Fisher Scientific Biosciences, Waltham, MA, USA). After confirmation of the sequence by DNA sequencing (BaseClear, Leiden, the Netherlands), the INHA promoter fragment was cut with BglII (Promega, Madison, WI, USA) and cloned into the luciferase reporter plasmid pGL4.10 (Promega). The correct orientation of the fragment was verified by sequencing. The pGL4.42 HRE-LUC vector containing four copies of a HRE was used as a positive control of HIF transcriptional activity and was obtained from Promega. A pRL-TK renilla luciferase control reporter vector used to correct for transfection efficiencies in dual-luciferase assay and the HIF1A and endothelial PAS domain protein 1 (EPAS1) expression vectors pFN21A were obtained from Promega. Empty pCDNA3.1(+) (Thermo Fisher Scientific) was used as a negative control.
Placenta collection
Term placentas were collected from uncomplicated pregnancies immediately after elective cesarean section with the approval of the ethical committee at Université Catholique de Louvain, Brussels, Belgium. Written informed consent was received from the patients.
Cytotrophoblast isolation and purification
One-third of the placenta was cut into one-inch cube pieces that were thoroughly washed with 0.9% ice-cold NaCl buffer. After removal of the placental membranes and large blood vessels, the pieces were minced. Tissue (72 grams) was digested with 2.4 U/ml Dispase II (Roche Diagnostics, Mannheim, Germany) under strong stirring for 1 h at 37°C. DNase I (100 U/ml) was added 15 min before the end of the incubation time. After serial filtration through 200, 100 and 40 µm filters, cells were purified in a 5-70% discontinuous Percoll TM gradient (GE Healthcare Bio-Sciences AB, Uppsala, Sweden).
The cellular fraction corresponding to a density of 1.048-1.062 g/L was collected. The Percoll solution was removed by dilution with serum-free Iscove's Modified Dulbecco Medium (IMDM) (GibcoBRL Life technologies, Paisley, UK) with 50 µg/ml gentamicin (Life technologies, Carlsbad, CA, USA) and centrifugation at 300 g for 5 min. The cell pellet was then resuspended in 5 ml 0.05% trypsin solution and incubated for 1 min at 37°C. Trypsin was inactivated by placing the tube on ice and adding 5 ml fetal bovine serum (FBS). After centrifugation at 300 g for 5 min, the cell pellet was resuspended in 50 ml FBS-free IMDM with 50 µg/ml gentamicin. Cell viability was assessed by Trypan Blue exclusion (Sigma-Aldrich, Saint-Louis, MO, USA). After cell counting, the cells were centrifuged at 300 g for 5 min and the medium replaced with 10% FBS-complete IMDM with 50 µg/ml gentamicin. Cell identification followed a protocol published elsewhere (Debieve et al., 2000) using anti-vimentin immunofluorescence. Vimentin, an intermediate filament only present in non-epithelial cells like fibroblasts, was detected in <5% of the cells. hCG secreted into the culture medium was used as a marker of trophoblast differentiation and was measured during cell culture in the department of Laboratory Medicine, Cliniques Universitaires Saint-Luc (Brussels, Belgium).
Cell culture
To achieve confluence, primary cytotrophoblasts cells were plated just after purification at a density of 4.0 × 10 5 cells/cm 2 . Cells were maintained under 21% O 2 or 2.5% O 2 at 37°C with 5% CO 2 in IMDM containing 10% FBS and 50 µg/ml gentamicin. After 2 h, the medium was removed and the cells were gently washed with 1× Dulbecco's phosphate-buffered saline (DPBS) to remove cells in excess. Fresh medium was then added and the cells were kept in the incubators for 72 h. The culture medium was changed every day. For chemical hypoxia and HIF inhibition, the cells were allowed to grow under 21% O 2 for 48 h. They were then treated with 500 µM DMOG and 200 µM DFX under 21% O 2 , or placed in 2.5% O 2 atmosphere with or without 40 µM KC7F2 and 30 µM TC-S7009 for 16 h.
Total RNA isolation and purification
Total RNA was extracted using a PureLink® RNA Mini kit (Ambion by Life Technologies, Carlsbad, CA, USA) following the manufacturer's protocol. Total RNA concentration was quantified with a NanoDrop 1000 spectrophotometer (Thermo Fischer Scientific, Wilmington, DE, USA). The ratios of absorbance at 260 and 280 nm, and at 260 and 230 nm, were used to estimate RNA quality, sufficient for subsequent RT-quantitative PCR (qPCR) experiments.
Reverse transcription
Cellular RNA (0.5 µg) was used as a template for the reverse transcription using qScript TM cDNA superMix (Quanta Biosciences, Gaithersburg, MD, USA). cDNA was diluted 10 times with RNase-free water.
Real-time PCR
Five nanograms of cDNAs and 0.1 µmol/l specific primers for INHA (forward: 5′-CAA-GTA-TGA-GAC-AGT-GCC-C-3′; reverse: 5′-GCC-ATC-TAT-TTC-CCA-ACT-CTG-3′), hCGB (forward: 5′-GCT-ACT-GCC-CCA-CCA-TGA-CC-3′; reverse: 5′-ATG-GAC-TCG-AAG-CGC-ACA-TC-3′), syncytin (SYNC) (forward: 5′-CCT-TCC-CTC-TAA-TTC-CCC-ATC-3′; reverse: 5′-TCC-ACT-CCA-GCC-ACT-TTA-AC-3′),
5′-CCA-CCT-CTA-AGG-CCA-TCT-TTG-3′) and RNA polymerase II (RPII) as reference gene (forward: 5′-GCA-CCA-CGT-CCA-ATG-ACA-T-3′; reverse: 5′-GTG-CGG-CTG-CTT-CCA-TAA-3′) were added to PowerSYBR ® Green
Master Mix (Applied Biosystem, Foster City, CA, USA). The PCR was performed on a StepOne Real-Time PCR System following the recommended protocol (Tm at 60°C). PCRs were performed in duplicate for each cDNA, averaged and normalized to RPII reference transcripts. The specificity of the amplification was verified by doing a melting curve which generated a single sharp peak for each product. RNA was quantified using the ΔΔCt method of relative quantification (Livak and Schmittgen, 2001 ).
Cell viability assay
Cell viability was measured by using a CellTiter-Glo luminescent cell viability assay (Promega) following the manufacturer protocol adapted to our experiments. This assay is based on intracellular ATP concentration present in metabolic active cells. The ATP released after lysing the cells is used as a cofactor during the luciferase reaction. The luminescent signal produced is directly proportional to the number of living cells. After medium removal, cells were washed with 1× cold PBS before adding 100 µl 1× PBS and 100 µl CellTiter-Glo reagent to each well. Plates were shaken for 2 min and incubated at room temperature for 10 min. From these samples, only 3 µl were used for measurement in a TD 20/20 luminometer (Promega). Six placentas were studied and each experiment was performed in quadruplicate.
Immunofluorescence
Trophoblast fusion was analyzed 48 h after plating. Cells were rinsed with PBS at 4°C and fixed for 10 min at 4°C in 100% methanol, rinsed again with PBS and stored at 4°C in PBS for no longer than 4 days. Preparations were preincubated in PBS containing 0.5% bovine serum albumin, 2.5% normal goat serum and 0.1% saponin for 15 min at 4°C, then incubated with primary monoclonal antibody diluted in the same solution overnight at 4°C. The following primary antibodies were used: mouse monoclonal anti-Desmoplakin I+II diluted at 1:100 (Abcam, England), rabbit monoclonal anti-keratin seven protein diluted at 1:100 (Cell Signaling Technology, MA, USA). Cells were rinsed for 5 min six times in PBS containing 0.1% saponin, followed by a 1 h incubation at room temperature with Alexa Fluor ® 488-conjugated goat anti-mouse IgG (H+L) F(ab') 2 fragment (Cell Signaling Technology), or with Alexa Fluor ® 555-conjugated goat anti-rabbit IgG (H+L) F(ab') 2 fragment (Cell Signaling Technology) diluted at 1:500 in the same solution. Cell nuclei were counterstained with DAPI when slides were mounted using ProLong ® Gold antifade reagent (Thermo Fisher Scientific) and fluorescence was examined using cellSens image acquisition software v1.6 (Olympus Corporation, Tokyo, Japan).
Transfections
Two hours after plating, the medium was removed and the cells were washed with 1× DPBS. After adding new medium, the cells were transfected with 1 µg −3910/+34 INHA promoter reporter plasmid or 0.25 ng of HRE-driven reporter plasmid and 10 ng of TK-renilla plasmid (internal control to correct for variations in transfection efficiencies) per well with Lipofectamine 3000 (Life Technologies). The cells were cultured for 72 h under 21% O 2 or 2.5% O 2 and the luciferase activity was assayed using Dual-Luciferase Assay System (Promega). Effective overexpression of HIF1A and EPAS1 was checked by western blotting (see below). Cytotrophoblasts were transfected with 1 µg of pcDNA3.1(+) empty vector (negative control), or HIF1A and EPAS1 overexpression vectors pFN21A. The cells were cultured for 72 h under 21% O 2 before being subjected to nuclear protein extraction.
For co-transfection experiments, the cells were transfected with 1 µg of INHA promoter reporter plasmid or 0.25 µg of HRE-driven luciferase reporter plasmid, 1 ng of pRL-TK and 0.5 ng of HIF1A or EPAS1 expression plasmids, or pCDNA3.1 (+) empty vector per well as control. The cells were cultured under 21% O 2 , and the dual-luciferase activity was assayed 72 h after transfection.
Inhibin A ELISA and HCGB protein quantification
Inhibin A in the cell supernatants was quantified by ELISA using a human INHIBIN A ELISA (AL-123, Bioactiva Diagnostica, Bad Homburg, Germany).
Secreted HCGB was quantified on a B.R.A.H.M.S. Kryptor Compact Plus immune analyzer (Thermo Fisher Scientific) in the department of Laboratory Medicine, Cliniques Universitaires Saint-Luc (Brussels, Belgium).
Nuclear protein extraction
Cells were detached from plates using a Trypsin-like enzyme (TrypLE, Life Technologies, Carlsbad, CA, USA). Nuclear protein extraction was performed using NE-PER ® kit (Thermo Scientific, Rockford, IL, USA) following the manufacturer protocol. 
Western blotting
Statistical analysis
Cytotrophoblast cells were isolated and purified from a minimum of four different placentas (n ≥ 4). The cell viability assay was performed in quadruplicate and the cDNA amplification by RT-qPCR in duplicate. Transfection experiments were performed in triplicate and were repeated a minimum of six times. All results are expressed as the mean ± SEM and were compared using one-way ANOVA and Tukey's multiple comparison test (GraphPad Prism® version 7.00 for windows, GraphPad software, San Diego, CA, USA). Two-tailed probabilities <0.05 were considered statistically significant. 
Results
Low
HIFs are involved in INHA expression induced by low-oxygen tension
Hypoxia-driven genes are regulated by HIF proteins that bind to HREs located in their promoter. We decided to identify and characterize the role of HIF proteins in hypoxia-enhanced INHA expression in an in vitro trophoblast cell culture that was partially differentiated. Cytotrophoblasts were cultured for 48 h under 21% O 2 to let them differentiate into syncytiotrophoblasts and allow increased INHA expression. Syncytialization at time of treatment was evaluated by measuring expression of genes characteristic of trophoblast fusion and differentiation, and by microscopic observations. Trophoblast fusion was checked by quantifying the expression of Syncytin-1 and E-cadherin (Coutifaris et al., 1991; Potgens et al., 2004) (Fig. 2A and B) . After 48 h, SYNC mRNA expression increased by 5.24-fold ± 1.8 and ECAD mRNA decreased by 70% compared to 0 h. Cell differentiation was checked by quantifying hCGB expression ( Fig. 2C and D) . HCGB mRNA expression increased by 40-fold and HCGB proteins were also detected in the cell supernatants. This increase in HCGB expression indicates that cytotrophoblasts were differentiating effectively. Fusion was also checked by immunofluorescence microscopy (Fig. 3) . Desmosomes expressed at the cell membranes were immunostained with Alexa fluor 488 (green) and cell nuclei were counterstained with DAPI (blue). To further confirm trophoblast identity, cytokeratin 7, which is an intracellular microfilament specifically present in trophoblasts was immunostained with Alexa fluor 555 (red). All the cells were cytokeratin 7-positive, confirming the purity of our cell preparations. After 2 days in culture, we observed the presence of multinucleated cells, but a lot of cells were still mononucleate. This indicates that, at time of treatment, the trophoblast population was a mix of syncytialized cells and undifferentiated cytotrophoblasts, a situation closed to what happens in placental villi.
The cells were then cultured for 16 h under 21% O 2 without or with drugs known to create a chemical hypoxia, or under 2.5% O 2 without or with HIF-specific inhibitors. Chemical hypoxia was achieved by treating the cells with 500 µM DMOG and 200 µM DFX, both known to upregulate HIF by inhibiting prolyl-4-hydroxylases-driven HIF degradation (Jaakkola et al., 2001; Ietta et al., 2006) . HIF inhibition was achieved by treating the cells with 40 µM KC7F2, an HIF1A specific inhibitor (Narita et al., 2009) , and 30 µM TC-S7009, an EPAS1 specific inhibitor (Scheuermann et al., 2013) .
We verified that the treatment had no toxic effect on the cells by assessing their viability (Fig. 4A) . We then quantified INHA mRNA expression (Fig. 4B) . In control cells, INHA mRNA expression increased Figure 1 Potentiation of INHA expression by low-oxygen tension in human primary cytotrophoblasts. Freshly isolated primary cytotrophoblasts from a minimum of four different placentas (n ≥ 4) were cultured in duplicate for 48 and 96 h either under 21% O 2 or 2.5% O 2 . Panel A: inhibin alpha (INHA) mRNA expression was determined by real-time quantitative PCR (RT-qPCR) at 48 and 96 h, normalized to RNA polymerase II (RPII) as constitutive control, and expressed relative to plating day (0 h). Values are mean ± SEM (n ≥ 4). Each condition was compared to control 0 h using Column Statistics analysis followed by Wilcoxon signed-rank test. One-way ANOVA followed by Dunn's multiple comparisons test was done to compare 2.5% O 2 to 21% O 2 . **P ≤ 0.01 compared to 21% O 2 . Panel B: Inhibin A protein secreted in the cell supernatants was measured by ELISA and normalized to total cellular proteins. Values are mean ± SEM and were compared using one-way ANOVA followed by Dunn's multiple comparisons test. *P ≤ 0.05 compared to 21% O 2 at 48 h. ***P ≤ 0.001 compared to 21% O 2 at 96 h. ****P ≤ 0.0001 compared to 2.5% O 2 at 48 h. by 3.63-fold ± 0.46 above Day 0 (undifferentiated cytotrophoblasts). When 500 µM DMOG and 200 µM DFX were added to the cells for 16 h, INHA mRNA expression increased by 7.98-fold ± 1.53 and 7.09-fold ± 1.03 compared to Day 0, respectively. This result indicates that HIF factors are effectively upregulating INHA mRNA expression. When the cells were cultured under 2.5% O 2 without HIF inhibitors for 16 h, INHA mRNA expression increased by 9.958-fold ± 1.38 compared to Day 0 (solid black bar). Low-oxygen tension for a short period of time was able to enhance INHA mRNA expression as efficiently as a 2-day culture under 2.5% O 2 (Fig. 1A) . When 40 µM KC7F2 and 30 µM TC-S7009 were added to the medium, INHA mRNA expression was only increased by 5.406-fold ± 1.38 and 5.036-fold ± 0.62 versus Day 0. This INHA mRNA expression was equivalent to the expression measured in cells cultured under 21% O 2 .
Next, we measured INHIBIN A protein secreted into the culture medium by ELISA and presented the results as fold change above control 21% O 2 (Fig. 4C) . The DMOG and DFX treatment effects on INHIBIN A secretion were not very strong, but the protein secretion profile was equivalent to the mRNA expression profile previously measured in the same samples (Fig. 4B) . Inhibition of HIF1A with KC7F2 induced a 75.86% decrease in hypoxia-induced INHA protein secretion. EPAS1 inhibition with TC-S7009 also decreased INHIBIN A protein secretion to a level equivalent to the one measured in the supernatants of cells cultured under 21% O 2 (control group).
We observed the same effect of the treatments on sVEGFR1 mRNA expression level, a gene known to be upregulated by HIF under hypoxic conditions (Gerber et al., 1997; Nevo et al., 2006; Tal et al., 2010) , or when the cells were transfected with an HRE-driven luciferase reporter vector ( Supplementary Figs 1 and 2) .
These results indicate that HIF is responsible for the increase in INHA expression, and that both HIF1A and EPAS1 are involved in this upregulation.
Cloned INHA promoter is activated by overexpressed HIF1A and EPAS1 in primary cytotrophoblasts cultured under 21% O 2
We decided to verify by transient transfection and dual luciferase assays that the INHA promoter was still able to respond to lowoxygen tension when cloned into a luciferase reporter plasmid (Fig. 5A) . After maintaining transfected cytotrophoblasts in culture for 72 h under 21% O 2 or 2.5% O 2 , we measured the luciferase activity. To correct for transfection efficiency variations, we co-transfected the 'plasmids' with a vector constitutively expressing the renilla luciferase gene (pRL-TK). The results were then represented as fold induction relative to 21% O 2 . When cytotrophoblasts were cultured under 2.5% O 2 , INHA transcriptional activity was induced by 2.55-fold ± 0.39 compared to the transcriptional activity measured under 21% O 2 . In the HRE experiment, we measured a 12-fold increase above control in luciferase activity. The effect of hypoxia on the cloned INHA promoter Figure 2 Determination of syncytialization after 48 h in culture under 21% O 2 . Fusion and differentiation were evaluated by measuring syncytin (SYNC), e-cadherin (ECAD) and HCGB mRNA expression by RT-qPCR (panel A, B and C) and HCGB protein secretion in the supernatants by ELISA (D). Cytotrophoblasts were isolated and purified from at least four different term placentas (n ≥ 4) and RT-qPCR and ELISA experiments were performed in duplicate. Values are mean ± SEM and were compared using one-way ANOVA followed by Dunn's multiple comparison test. **P ≤ 0.01, ***P ≤ 0.001 compared to 0 h (cDNA from undifferentiated cytotrophoblasts for qPCR and fresh culture medium for ELISA). Figure 3 Immunostaining of cytotrophoblasts at 48 h. Cells were cultured under 21% O 2 for 48 h. Cell membranes were visualized using an antibody raised against desmoplakin (green). Trophoblastic identity was checked by using an antibody raised against cytokeratin 7 (red). Nuclei were counterstained with DAPI (blue). (Original magnification ×200).
was equivalent to the effect on endogenous INHA promoter activity as measured here by qPCR.
To confirm that HIF proteins are involved in the transcriptional regulation of INHA gene, plasmids allowing overexpression of HIF1A and EPAS1 were cotransfected with the INHA promoter-driven luciferase reporter plasmid and the cells were cultured under 21% O 2 for 72 h. The control group consisted of cells transfected with the inert empty vector pCDNA3.1(+).
First, we verified that HIF1A and EPAS1 were efficiently overexpressed by western blotting using specific antibodies raised against HIF proteins (Fig. 5B ). Cells were transfected with an empty control vector (lane A), HIF1A overexpressing vector (lane B) or EPAS1 overexpressing vector (lane C). Anti-HIF1A antibody specifically recognized HIF1A in HIF1A overexpressing nuclear extract (lane B). Anti-EPAS1 antibody specifically recognized EPAS1 in EPAS1 overexpressing nuclear extract (lane C). This result indicated that both HIF1A and EPAS1 were efficiently and strongly overexpressed in differentiating cytotrophoblasts cultured under 21% O 2 .
Next, the cells were transfected with the INHA-promoter luciferase reporter vector or the HRE-driven luciferase reporter vector, the renilla luciferase internal control vector and HIF overexpression vectors. HIF1A overexpression increased INHA transcriptional activity by 2-fold ± 0.37 and EPAS1 overexpression increased it by 2.81-fold ± 0.8 (Fig. 5C ). Both HIF1A and EPAS1 were able to increase the HREdriven luciferase activity. There was a 2.23-fold ± 0.5 increase when HIF1A was overexpressed and 7.69-fold ± 2.0 when EPAS1 was overexpressed. Interestingly, EPAS1 had a stronger transcriptional activity than HIF1A in trophoblasts.
Discussion
During pregnancy, inhibin A is mainly produced by the syncytiotrophoblasts of the placenta. Its production and secretion increase throughout gestation and during in vitro differentiation of primary term cytotrophoblasts into syncytiotrophoblasts.
Inhibin A is a heterodimeric glycoprotein formed by two subunits, alpha and beta, and we previously demonstrated that inhibin alpha subunit expression was the limiting factor of inhibin A production and secretion. Promoter studies in the murine gonads and human placenta identified numerous binding sites for transcription factors within the INHA promoter, upregulating its transcriptional activity under 21% O 2 . We also showed that hypoxia, which is thought to be responsible for aberrant gene expression in pregnancy-related diseases like preeclampsia and IUGR, did not inhibit but instead potentiated INHA expression. This result is consistent with higher serum concentrations of inhibin A measured in pre-eclamptic women compared to normotensive pregnant women. In this report, we showed that HIF1 was the transcription factor responsible for this potentiation since inhibition of HIF1 degradation under 21% O 2 increased INHA mRNA and protein expression. Both HIF1A and EPAS1 were able to upregulate INHA mRNA and protein expression under 2.5% O 2 as shown by the use of specific inhibitors. Transient transfection experiments further confirmed this result. HIF1A and EPAS1 overexpression in primary term cytotrophoblasts was followed by an increase in INHA promoterdriven luciferase activity. Figure 4 Role of hypoxia-inducible factor-1 (HIF1) in INHA overexpression. Cytotrophoblasts isolated and purified from at least four different placentas (n ≥ 4) were allowed to differentiate under 21% O 2 for 48 h. Cells were then cultured under 21% O 2 for 16 h in presence of dimethyl sulfoxyde (DMSO) as vehicle control (Control), 500 µM dimethyl oxalyl glycine (DMOG) and 200 µM Deferoxamine mesylate to inhibit HIF1 degradation by the proteasome. Another group of cells was cultured under 2.5% O 2 for 16 h and treated with DMSO (Control), 40 µM HIF1A specific inhibitor KC7F2 and 30 µM EPAS1 specific inhibitor TC-S7009. (A) Cell viability was assessed to determine the potential toxicity of the drugs. The control group comprised untreated cells, and cell viability was fixed at 100%. (B) INHA mRNA expression was measured by RT-qPCR and normalized to RPII as constitutive control, and expressed relative to plating day (Day 0). (C) Inhibin A secreted in the cell supernatants was measured by ELISA. Values for RT-qPCR and ELISA are mean ± SEM (n ≥ 4) and were compared using one-way ANOVA followed by Bonferroni's multiple comparison test. *P ≤ 0.05 and **P ≤ 0.01 compared to 2.5% O 2 Control group. ****P ≤ 0.0001 compared to 21% O 2 control group.
In our experiments, we used relatively pure preparations of cytotrophoblasts (<5% contaminating cells) reducing the possibility that other cell types influence HIF1 expression through secretion of growth hormones and cytokines (Zelzer et al., 1998; Feldser et al., 1999; Hellwig-Burgel et al., 1999; Laughner et al., 2001; Fukuda et al., 2002; Stiehl et al., 2002) . Cytotrophoblasts were also allowed to begin differentiation before being treated with molecules that mimic hypoxia or being exposed to 2.5% O 2 for 16 h. Interestingly, 16 h of physiological Figure 5 Effect of HIF1A and EPAS1 overexpression on cloned INHA promoter activity in primary term cytotrophoblasts. Panel A: primary term cytotrophoblasts were transfected with 1 µg of a 3.9 kb INHA promoter-firefly luciferase construct or hypoxia-responsive element (HRE)-driven luciferase reporter vector and 10 ng of a TK minimal promoter-renilla luciferase construct. The cells were cultured for 72 h under 21% O 2 or 2.5% O 2 . Dualluciferase activity was then measured and fold activity above 21% O 2 was plotted. The experiment was done in triplicate and repeated a minimum of six times (n = 6). Values are mean ± SEM and were compared using column statistics analysis followed by Wilcoxon signed-rank test. *P ≤ 0.05 and **P ≤ 0.01 compared to 21% O 2 . Panel B: representative immunoblot showing that HIF1A and EPAS1 are efficiently overexpressed in term primary cytotrophoblasts cultured under 21% O 2 . Cytotrophoblasts were transfected with 0.5 µg of pCDNA3.1(+) mock vector control (lane A), pFN21A-HIF1A (lane B) and pFN21A-EPAS1 (lane C). Seventy-two hours after transfection, total nuclear proteins were extracted and 20 µg of protein extract were subjected to immunoblot with anti-HIF1A, anti-EPAS1 and anti-TATA-binding protein antibodies. MW, molecular weight; kD, kiloDalton; Ab, antibody. Panel C: overexpressed HIF1A and EPAS1 upregulate INHA promoter activity and HRE-driven transcription. Cytotrophoblasts were transfected with 1 µg of INHA promoter-driven luciferase reporter plasmid or 0.25 µg of HRE-luciferase reporter plasmid, 10 ng of renilla luciferase internal control vector and 0.5 µg of pCDNA3.1(+) (control), or pFN21A-HIF1A and pFN21A-EPAS1 overexpression vectors. The cells were transfected for 72 h. Dual-luciferase activity was then measured and fold activity above control was plotted. The experiment was done in triplicate and repeated a minimum of six times (n = 6). Values are mean ± SEM and were compared using one-way ANOVA followed by Dunn's multiple comparison test. *P ≤ 0.05 and **P ≤ 0.01 compared to control. or chemical hypoxia were able to increase INHA expression as efficiently as when cells were cultured for 72 h under 2.5% O 2 . We previously observed that not only HIF1A and EPAS1 mRNAs but also proteins were expressed in differentiating cytotrophoblasts under 21% O 2 (Depoix et al., 2016) and that their expression increased during differentiation. It is possible that this increase under normoxia is necessary to allow a fast and strong response by differentiating cytotrophoblasts to a sudden hypoxia.
By using inhibitors that specifically inhibit HIF1A and EPAS1, we demonstrate that both factors are able to increase INHA expression. Cotransfection of HIF1 expression vectors with INHA promoterdriven luciferase reporter plasmid indicates that EPAS1 appears to be better than HIF1A at transactivating the INHA promoter in primary human term cytotrophoblasts. This may be related to the fact that, in undifferentiated cytotrophoblast, there are more EPAS1 transcripts than HIF1A transcripts (Depoix et al., 2016) . EPAS1, more than HIF1A, may play an important role in gene expression regulation during differentiation. In our cell culture model, cells are cultured under chronic hypoxia, and it is known that EPAS1 drives the response to chronic hypoxia while HIF1A is involved in the cellular response to acute hypoxia (Holmquist-Mengelbier et al., 2006) .
INHA gene expression is increased during in vitro syncytialization under normoxic conditions but it is further increased when cells are differentiating under low-oxygen tension. This means that HIF1 activity is added to the transcriptional activities of the pool of transcription factors already involved in INHA gene upregulation. This regulation by HIF1 during placental development is important during the first trimester of pregnancy. The role of HIF1A in hypoxia-responsive gene regulation has been extensively studied under very low-oxygen tension for short periods of time, but chronic hypoxia may have a very different effect on the gene expression during placental formation (Pringle et al., 2010) . We previously reported that cytotrophoblasts cultured for 4 days were able to differentiate under 2.5% O 2 like first-trimester cytotrophoblasts. Then, 2.5% O 2 , which can be considered as hypoxia in other systems, may be considered as normoxia for first-trimester cytotrophoblasts. Experiments in mice indicated that HIF1 is actively involved during early placental formation. Hif1a overexpression in pregnant mice was followed by a decrease in placental weight and an increase in sVEGFR1 and sEng concentrations in the serum (Tal et al., 2010) as in pre-eclampsia and IUGR. Moreover, knock-out experiments of Hif1 genes in mice indicate that both HIF1A and EPAS1 are necessary for normal placentation during early pregnancy (Cowden Dahl et al., 2005) .
Gene promoter transactivation by HIF necessitates DNA binding to the consensus core sequence RCGTG (where R is A or G) (Wenger et al., 2005) . Actually, no HRE has been described in the INHA gene promoter but, in a genome-wide analysis of HIF1 DNA binding using anti-HIF1A and anti-EPAS-1 antibodies, it was reported that INHA gene was among the immunoprecipitated loci (Mole et al., 2009) . After analysis of the 4 kb INHA promoter used in our transfection experiments we were unable to isolate a sequence that could act as an HRE. It is possible that the nucleotide sequence of this HRE may greatly differ from the consensus sequence. More experiments need to be done to determine the promoter fragment that is responsive to hypoxia.
Another possibility is that the effect of HIF1 proteins on INHA gene promoter activity may be indirect. INHA gene expression is regulated by cAMP through binding of CREB to a CRE. It is also possible that HIF1A binds to the same cAMP-response element as demonstrated in the plasminogen activator inhibitor-1 gene promoter (Dimova et al., 2007 (Dimova et al., , 2010 . Moreover, the activator protein p300/CBP, which interacts with CREB, also interacts with HIF1A in hypoxia (Arany et al., 1996) , and it was reported that HIF1A, AP-1, GATA-2 and p300/CBP are able to interact to regulate endothelin-1 gene expression in hypoxia (Yamashita et al., 2001) .
Finally, HIF1 proteins can also up or downregulate the expression of genes coding for proteins involved in the regulation of the INHA gene promoter. A study comparing vhl mutants versus wild-type zebrafish identified hypoxia-regulated genes with potential HREs (Greenald et al., 2015) . Among the differentially regulated genes with a fold change ≥2, GATA-4 gene was upregulated while NR5A5 gene was downregulated. NR5A5 is the zebrafish equivalent of the liver receptor homolog-1 in humans, an orphan nuclear receptor that cooperates with GATA factors to regulate INHA promoter activity (Robert et al., 2006) . Another gene coding for the transcriptional coactivator CBP/p300-interacting transactivator, with a Glu/Asp-rich carboxyl-terminal domain-2 (Cited-2), important for trophoblast formation and placental vascularization (Withington et al., 2006) was upregulated. Three core HRE sequences have also been identified in its promoter (Bhattacharya et al., 1999) . CITED-2 has not been shown to be involved in INHA gene expression, but we can speculate that it potentially participates in INHA gene regulation by interacting with TFAP2 (Braganca et al., 2003) . Moreover, two core HRE sequences were also identified in the promoter of the gene coding for the orphan nuclear receptor NUR77 (Choi et al., 2004) . It is very interesting that genes encoding transcription factors and cofactors identified in the pool of proteins already known to regulate INHA gene expression are potentially regulated by hypoxia through HREs.
In conclusion, our findings indicate that the enhanced INHA gene expression observed when partially differentiated cytotrophoblasts are cultured under low-oxygen tension is associated with the transcriptional activities of HIF1. Both HIF1A and EPAS1, along with other transcription factors are able to upregulate INHA gene expression. More experiments are required in order to distinguish between the direct and indirect effects of HIF1 on INHA gene expression. A better understanding of HIF1 activation and identification its target genes during early placental formation are necessary to clarify all the molecular events at the origin of abnormal placentation observed in pregnancyrelated diseases.
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